MiCareo’s technologies can isolate and profile single live cells and rare cells from whole blood, including liquid biopsies of CTCs and tumor-related immune cells. Our fully automated MiSelect instrument delivers the full range of biological and genomic information that will accelerate biomarker discovery, and immuno-oncology research and development.